Article Details

Client Novo Nordisk Expands AI-Based Cardiometabolic Drug Discovery Collaboration with ...

Retrieved on: 2025-01-09 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Client Novo Nordisk Expands AI-Based Cardiometabolic Drug Discovery Collaboration with .... View article details on hiswai:

Excerpt

That collaboration was worth up to $2.7 billion in milestones, plus research and development funding and potential royalty payments. Under the ...

Article found on: www.ropesgray.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up